What will the aesthetic medicine look like in 2021? Dr. Suneel Chilukuri offers his perspective on how the pandemic will influence the practice in the New Year.
An exploration of the feasibility of using laser technology to detect changes in microvasculature during the acne lesion healing progress and to introduce a microvasculature-based biomarker in evaluating the treatment and grading of acne.
The combination of encorafenib plus binimetinib significantly improved overall survival versus vemurafenib in patients with BRAF-mutant melanoma, updated results of the randomized, phase three COLUMBUS trial show.
A panel discussion on the increasing trend of total body skin lightening ― and ethical and health concerns associated with skin lightening ― was this year's most discussesd and controversial topic.
In April we reviewed the first five tips to help boost your resilience and well being in 2018. Below are the final five in the second part of this two-part article.
Qbrexza was approved earlier this year for primary axillary hyperhidrosis. And, now, other treatments are under study. In his presentation at this week’s Fall Clinical Dermatology Conference in Las Vegas, Dr. David Pariser summarizes the latest research.
Marketing expert Justin Knott explains how to grow your Instagram following as part of a successful digital practice marketing strategy.
WE medical trip to India ends in eye-opening lessons learned.
Pennsylvania Dermatology Partners tells its story of technological support and success.
Life-threatening emergency cases may be rare, but they can be complex. At EADV this week, experts review cases physicians should be aware of.
Dermatofibrosarcoma is a common, but unusual locally aggressive cutaneous tumor. Its characteristic tentacle can grow into surrounding fat, muscle and even bone. For dermatologists this means that understanding treatment options is a priority, says a physician reporting from EADV 2018.
As news of benzene contamination in benzoyl peroxide products continues to raise safety discussions, Steve Xu, MD, MSc, advocates for stricter regulations, increased research, and the consideration of safer acne treatment alternatives.
In recognition of the first anniversary of our Innovation column, Drs. Steve Xu and William Ju reflect on the range of topics covered throughout the year and highlight what's to come.
Cosmetic products with prebiotics, probiotics and postbiotics may be beneficial in treating eczema, a physician reported at the Fall Clinical Dermatology Conference held earlier this month in Las Vegas.
Patients are increasingly seeking to have benign lesions removed and today, there are a number of treatment options available to safely and effectively remove unwanted lesions. Suneel Chilukuri, M.D., reviewed these options during a presentation at the Fall Clinical Dermatology Conference held this week in Las Vegas.
Long lauded for its ability to reduce the appearance of wrinkles, botulinum toxin is now being considered for reducing scarring.
In this month's Innovation column, Steve Xu, M.D. and Morgan Nguyen discuss how to incorporate innovation into medical societies.
The use of cloudbased platforms to send, receive and store patient data in teledermatology adds security risks.
Digital recruitment for clinical studies may be more effective than traditional methods, according to a new study.
Digital recruitment for clinical studies may be more effective than traditional methods, according to a new study.
Digital recruitment for clinical studies may be more effective than traditional methods, according to a new study.
Digital recruitment for clinical studies may be more effective than traditional methods, according to a new study.
In this article, Katja Reuter, Ph.D. critiques a study by Katz and colleagues on the effectiveness of using digital platforms to recruit for an atopic dermatitis study.
Researchers recently undertook an epidemiologic study to investigate the prevalence of palmoplantar pustulosis (PPP) and co-existing plaque psoriasis. Read what they discovered in this article.
Industry relationships are essential for innovation in dermatology. In this month's column, Steve Xu, M.D., and Michael L. Sierra, Ph.D., provide their insight on collaborating with industry.
Healthcare disparities exist in all fields of medicine, including dermatology. We seek to address these disparities in this article by outlining the differences in epidemiology, presentation, access and outcomes of five conditions in patients with skin of color.
Allison Truong, M.D., FAAD, provides some useful tips to help health care professionals on the frontlines of the COVID-19 pandemic combat mask irritation and acne.
In this follow up to last month’s Innovations column on intellectual property and technology transfer, Raymond A. Miller, J.D., and Steve Xu, M.D., FAAD discuss how to utilize patents to maximize value for your venture.
In this pipeline report, Dermatology Times presents insights into Hh pathway inhibitors currently in phase 2 and phase 3 for the treatment of basal cell carcinoma.